Gill, P. S., and N. Grewal. “Mirabegron: First β3 Agonist in Treatment of Overactive Bladder”. International Journal of Basic & Clinical Pharmacology, vol. 1, no. 2, Feb. 2017, pp. 120-1, https://www.ijbcp.com/index.php/ijbcp/article/view/1410.